Contribution of Na+-independent nucleoside transport to ribavirin uptake in the rat intestine and human epithelial LS180 cells

European Journal of Pharmacology

Volumn 601, Issue 1-3, 2008, Pages 61-65

  Takaai, Mari ^a   Morishita, Hiroki ^a   Ishida, Kazuya ^a   Taguchi, Masato ^a   Hashimoto, Yukiya ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Intestinal absorption; LS180 cell; Na+ independent nucleoside transporter; Ribavirin

Indexed keywords

INOSINE; MIZORIBINE; NITROBENZYLTHIOINOSINE; NUCLEOSIDE TRANSPORTER; RIBAVIRIN; SODIUM ION;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG CLEARANCE; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; MALE; NONHUMAN; NUCLEOSIDE TRANSPORT; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIVIRAL AGENTS; BIOLOGICAL TRANSPORT; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; MALE; NUCLEOSIDE TRANSPORT PROTEINS; RATS; RATS, WISTAR; RIBAVIRIN; SODIUM; THIOINOSINE; TIME FACTORS;

EID: 56949106503     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.10.047     Document Type: Article

References (19)

1. Baldwin S.A., Beal P.R., Yao S.Y., King A.E., Cass C.E., and Young J.D. The equilibrative nucleoside transporter family, SLC29. Pflugers. Arch. 447 (2004) 735-743
2. Dixit N.M., and Perelson A.S. The metabolism, pharmacokinetics and mechanisms of antiviral activity of ribavirin against hepatitis C virus. Cell. Mol. Life Sci. 63 (2006) 832-842
3. Fernandez H., Banks G., and Smith R. Ribavirin: a clinical overview. Eur. J. Epidemiol. 2 (1986) 1-14
4. Fukumori S., Murata T., Taguchi M., and Hashimoto Y. Rapid and drastic induction of CYP3A4 mRNA expression via vitamin D receptor in human intestinal LS180 cells. Drug Metab. Pharmacokinet. 22 (2007) 377-381
5. Glue P. The clinical pharmacology of ribavirin. Semin. Liver Dis. 19 (1999) 17-24
6. Gray J.H., Owen R.P., and Giacomini K.M. The concentrative nucleoside transporter family, SLC28. Pflugers Arch. 447 (2004) 728-734
7. Govindarajan R., Bakken A.H., Hudkins K.L., Lai Y., Casado F.J., Pastor-Anglada M., Tse C.M., Hayashi J., and Unadkat J.D. In situ hybridization and immunolocalization of concentrative and equilibrative nucleoside transporters in the human intestine, liver, kidneys, and placenta. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293 (2007) R1809-R1822
8. Hoque K.M., Chen L., Leung G.P., and Tse C.M. A purine-selective nucleobase/nucleoside transporter in PK15NTD cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294 (2008) R1988-R1995
9. Ishida K., Takaai M., and Hashimoto Y. Pharmacokinetic analysis of transcellular transport of quinidine across monolayers of human intestinal epithelial Caco-2 cells. Biol. Pharm. Bull. 29 (2006) 522-526
10. Koizumi T., Arita T., and Kakemi K. Absorption and excretion of drugs. XIX. Some pharmacokinetic aspects of absorption and excretion of sulfonamides. (1). Absorption from rat stomach. Chem. Pharm. Bull. 12 (1964) 413-420
11. Lin C.C., Yeh L.T., Luu T., Lourenco D., and Lau J.Y. Pharmacokinetics and metabolism of [(14)C]ribavirin in rats and cynomolgus monkeys. Antimicrob. Agents Chemother. 47 (2003) 1395-1398
12. Molina-Arcas M., Bellosillo B., Casado F.J., Montserrat E., Gil J., Colomer D., and Pastor-Anglada M. Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia. Blood 101 (2003) 2328-2334
13. Moriya Y., Nakamura T., Okamura N., Sakaeda T., Horinouchi M., Tamura T., Aoyama N., Kasuga M., and Okumura K. Comparison of synthetic DNA templates with authentic cDNA templates in terms of quantification by real-time quantitative reverse transcription polymerase chain reaction. Biol. Pharm. Bull. 29 (2006) 535-538
14. Pastor-Anglada M., Cano-Soldado P., Molina-Arcas M., Lostao M.P., Larráyoz I., Martínez-Picado J., and Casado F.J. Cell entry and export of nucleoside analogues. Virus Res. 107 (2005) 151-164
15. +-nucleoside purine (N1) transporter. Pharm. Res. 6 (1998) 950-952
16. Podgorska M., Kocbuch K., and Pawelczyk T. Recent advances in studies on biochemical and structural properties of equilibrative and concentrative nucleoside transporters. Acta. Biochim. Pol. 52 (2005) 749-758
17. Takaai M., Suzuki H., Ishida K., Tahara K., and Hashimoto Y. Pharmacokinetic analysis of transcellular transport of levofloxacin across LLC-PK1 and Caco-2 cell monolayers. Biol. Pharm. Bull. 30 (2007) 2167-2172
18. Yamamoto T., Kuniki K., Takekuma Y., Hirano T., Iseki K., and Sugawara M. Ribavirin uptake by cultured human choriocarcinoma (BeWo) cells and Xenopus laevis oocytes expressing recombinant plasma membrane human nucleoside transporters. Eur. J. Pharmacol. 557 (2007) 1-8
19. Ward J.L., Sherali A., Mo Z.P., and Tse C.M. Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine. J. Biol. Chem. 275 (2000) 8375-8381